Weight Loss Drug Comparison 2026
Wegovy vs Mounjaro: Which Weight Loss Medication Saves You More?
Both are FDA-approved for chronic weight management, but they differ in mechanism, savings, and FDA indications. Here's the complete breakdown.
💰 Winner: Mounjaro (For Savings)
Mounjaro offers up to $650/month savings vs Wegovy's $500/month. However, Wegovy is FDA-approved for weight loss while Mounjaro is approved only for diabetes (though prescribed off-label for weight loss).
Quick Comparison
| Feature | Wegovy | Mounjaro |
|---|---|---|
| Active Ingredient | Semaglutide (GLP-1 only) | Tirzepatide (dual GIP/GLP-1) |
| FDA Indication | Chronic weight management ⭐ | Type 2 diabetes only |
| Typical Cash Price | ~$1,349/month | ~$1,023/month |
| With Savings Card | As low as $0/month (up to $500 off) | $25/month (up to $650 off) ⭐ |
| Max Savings/Year | $6,000/year | $7,800/year ⭐ |
| Average Weight Loss | ~15% body weight (clinical trials) | ~15-22% body weight ⭐ |
| Eligibility | Commercial insurance required | Commercial insurance required |
| Program Duration | Up to 13 fills | Up to 24 months |
| Manufacturer | Novo Nordisk | Lilly |
Detailed Breakdown
Wegovy (Semaglutide)
- Mechanism: GLP-1 receptor agonist
- FDA Approved For: Chronic weight management (obesity/overweight with comorbidities)
- Copay Card: As low as $0/prescription
- Max Savings: $500/month
- Weight Loss: ~15% body weight in 68 weeks
- Dosing: Once-weekly injection
- Enrollment: Online at Wegovy.com
Mounjaro (Tirzepatide)
- Mechanism: Dual GIP/GLP-1 receptor agonist
- FDA Approved For: Type 2 diabetes (used off-label for weight loss)
- Copay Card: $25/prescription
- Max Savings: $650/month
- Weight Loss: ~15-22% body weight in trials
- Dosing: Once-weekly injection
- Enrollment: Online at Mounjaro.com
Which Should You Choose?
Choose Wegovy If:
- You need an FDA-approved weight loss medication (not diabetic)
- Your insurance requires on-label prescriptions for weight management
- You prefer a medication specifically studied for obesity
- Your insurance covers Wegovy for weight loss
Choose Mounjaro If:
- You have type 2 diabetes (on-label use)
- You want potentially greater weight loss (15-22% vs 15%)
- You want higher savings ($650/month vs $500/month)
- Your doctor prescribes it off-label for weight management
Key Differences
FDA Approval Status
Wegovy is FDA-approved specifically for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related conditions. Mounjaro is approved only for type 2 diabetes, though it's increasingly prescribed off-label for weight loss after showing superior results in trials.
Mechanism of Action
Mounjaro is a dual GIP/GLP-1 receptor agonist, activating two incretin pathways. Wegovy is a GLP-1-only agonist. This dual mechanism may explain Mounjaro's higher weight loss in head-to-head studies, though more research is needed.
Insurance Coverage Nuances
Many insurance plans cover Wegovy for weight loss if you meet BMI requirements. However, they may not cover Mounjaro for weight loss since it's off-label. If you have diabetes, Mounjaro is usually covered and offers higher savings. Check your formulary before assuming either is covered.
Savings Card Differences
Wegovy's savings card can reduce copay to $0 per month (up to $500 off), while Mounjaro's card brings it to $25/month (up to $650 off). If your copay is under $25, Wegovy may be cheaper. If it's over $650, Mounjaro offers more savings.
Frequently Asked Questions
Can I use Mounjaro for weight loss if I don't have diabetes?
Yes, but it's considered off-label use. Your doctor can prescribe it, but insurance may not cover it for weight loss alone. In this case, Wegovy (FDA-approved for weight loss) might be a better choice. Note: Zepbound (tirzepatide for weight loss) is now FDA-approved and may be an alternative.
Which causes more weight loss: Wegovy or Mounjaro?
Clinical trials show Mounjaro leads to slightly more weight loss (15-22% vs ~15% for Wegovy). However, individual results vary widely based on diet, exercise, and metabolism. Both are highly effective for weight management when combined with lifestyle changes.
Do both savings cards require insurance?
Yes. Both Wegovy and Mounjaro copay cards require commercial (private) insurance. Medicare and Medicaid patients are not eligible. However, both manufacturers offer Patient Assistance Programs for uninsured patients who meet income requirements.
Can I switch from Wegovy to Mounjaro?
Yes, but you'll need a new prescription and insurance approval. Some patients switch to Mounjaro seeking greater weight loss or if Wegovy isn't covered. Consult your doctor about proper dosing transitions and potential side effects when switching.
How long does enrollment take?
Both programs allow instant enrollment online. Complete the application in 5-10 minutes and receive a digital savings card immediately. Bring the card to your pharmacy or provide the card number when filling your prescription.
Ready to Start Saving?
Access official manufacturer savings programs directly — no middlemen, no hidden fees.